Evolent Health
Stock Forecast, Prediction & Price Target
Evolent Health (EVH) stock Price Target by analysts
$33
Potential upside: 266.25%
Evolent Health price prediction
What is Evolent Health stock analysts` prediction?
Evolent Health stock forecast: Based on 2 Wall Street analysts` predicted price targets for Evolent Health in the last 3 months, the avarage price target is $33, with a high forecast of $NaN. The average price target represents a 266.25% change from the last price of $9.01.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Evolent Health stock Price Target by analysts
Full breakdown of analysts given Evolent Health price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Mohan Naidu Oppenheimer | 0% 0/1 | 10 months ago | $28 210.76% upside | $12.59 | StreetInsider | Previous targets (0) |
Jeff Garro Stephens | 0% 0/1 | 11 months ago | $38 321.75% upside | $24.96 | TheFly | Previous targets (0) |
Jailendra Singh Truist Financial | 0% 0/2 | about 1 year ago | $33 266.25% upside | $20.87 | TheFly | Previous targets (1) |
Sean Dodge RBC Capital | 0% 0/1 | over 1 year ago | $42 366.14% upside | $22.04 | StreetInsider | Previous targets (0) |
Jailendra Singh Truist Financial | 0% 0/2 | over 1 year ago | $28 210.76% upside | $23.75 | StreetInsider | Previous targets (1) |
Jessica Tassan Piper Sandler | 0% 0/1 | over 1 year ago | $51 466.03% upside | $29.6 | StreetInsider | Previous targets (0) |
Richard Close Canaccord Genuity | 0% 0/1 | over 1 year ago | $44 388.34% upside | $32.73 | StreetInsider | Previous targets (0) |
Unknown BTIG | N/A | about 3 years ago | $50 454.93% upside | $35.21 | Benzinga | N/A |
Unknown Canaccord Genuity | N/A | over 3 years ago | $45 399.44% upside | $26.91 | Benzinga | N/A |
Evolent Health Financial Estimates
Evolent Health Revenue Estimates
Evolent Health EBITDA Estimates
Evolent Health Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $907.95M N/A | $1.35B 48.90% | $1.96B 45.25% | Avg: $2.96B Low: $2.84B High: $3.19B avg. 51.08% | Avg: $3.40B Low: $3.31B High: $3.56B avg. 14.84% | Avg: $3.85B Low: $3.75B High: $4.03B avg. 13.17% | Avg: $4.41B Low: $4.29B High: $4.61B avg. 14.48% |
Net Income
% change YoY
| $-30.28M N/A | $-18.70M 38.24% | $-113.04M -504.45% | Avg: $73.38M Low: $-55.62M High: $560.70M avg. 164.91% | Avg: $89.51M Low: $-10.01M High: $157.97M avg. 21.97% | Avg: $295.92M Low: $285.43M High: $313.33M avg. 230.60% | Avg: $382.70M Low: $369.13M High: $405.21M avg. 29.32% |
EBITDA
% change YoY
| $90.28M N/A | $7.36M -91.84% | $-24.78M -436.75% | Avg: $44.04M Low: $42.25M High: $47.48M avg. 277.72% | Avg: $50.58M Low: $49.20M High: $52.87M avg. 14.84% | Avg: $57.25M Low: $55.69M High: $59.84M avg. 13.17% | Avg: $65.54M Low: $63.76M High: $68.51M avg. 14.48% |
EPS
% change YoY
| -$0.35 N/A | -$0.2 42.85% | -$1.28 -540% | Avg: $0.99 Low: -$0.5 High: $5.04 avg. 177.65% | Avg: $0.62 Low: -$0.09 High: $1.42 avg. -37.72% | Avg: $2.66 Low: $2.57 High: $2.82 avg. 329.73% | Avg: $3.44 Low: $3.32 High: $3.64 avg. 29.32% |
Operating Expenses
% change YoY
| $279.53M N/A | $336.46M 20.36% | $531.68M 58.02% | Avg: $825.55M Low: $791.97M High: $889.91M avg. 55.27% | Avg: $948.11M Low: $922.26M High: $991.01M avg. 14.84% | Avg: $1.07B Low: $1.04B High: $1.12B avg. 13.17% | Avg: $1.22B Low: $1.19B High: $1.28B avg. 14.48% |
FAQ
What is Evolent Health stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 111.70% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is -55.62M, average is 73.38M and high is 560.70M.
What is Evolent Health stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 23.39% in 2025-2028.
We have gathered data from 11 analysts. Their low revenue estimate is $2.84B, average is $2.96B and high is $3.19B.
What is Evolent Health stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 124.74% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is -$0.5, average is $0.99 and high is $5.04.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Evolent Health stock. The most successful analyst is Mohan Naidu.